
The past several decades have revealed certain challenges that are inherent to zzso zzso with regards to zzso testing and setting treatment zzso for such a rare and zzso zzso Despite this, significant advances have been made through the efforts of scientists, clinicians and patients zzso We are now entering a molecular era of cancer and current biotechnology is beginning to unravel the zzso zzso of these often devastating zzso As our understanding of these zzso zzso so does our list of potential treatment zzso The impetus now lies with the zzso community to direct zzso research and subsequently the development and clinical testing of novel compounds in a fashion that best serves this unique patient zzso To do so, we must continue to integrate the lessons of the past with the resources and promise of the zzso This review will outline current areas of therapeutic interest in zzso zzso with regard to agents that have reached clinical zzso 

